NEW YORK, May 12, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. (HOTH), a patient focused biopharmaceutical company, today announced that they have entered into a mutual agreement with Algorithm ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback